Novus Therapeutics begins phase 1 trial of OP0201 in otitis media
Clinical trial news : Novus Therapeutics has initiated a phase 1 pharmacodynamics clinical trial of its lead candidate OP0201 for
Continue readingCoverage of Global Pharma Industry News
Clinical trial news : Novus Therapeutics has initiated a phase 1 pharmacodynamics clinical trial of its lead candidate OP0201 for
Continue readingGerman pharma company Boehringer Ingelheim has exercised its option to acquire 100% of Austria-based oncolytic virus company ViraTherapeutics for €210
Continue readingGerman pharma company Boehringer Ingelheim said that Cyltezo, a biosimilar to AbbVie psoriasis drug Humira, achieved clinical equivalence to the
Continue readingSwiss drugmaker Novartis unveiled new data on Entresto (sacubitril/valsartan) from a phase 4 study which confirms that the heart failure
Continue readingBioNTech, a German biotechnology company, has joined forces with US pharma giant Pfizer to develop mRNA-based flu vaccines as part
Continue readingDutch pharma company Norgine has opened new offices in its largest product sales market – Germany at Wettenberg as part
Continue readingNovartis has agreed to acquire the exclusive global development and marketing rights of atopic dermatitis drug MOR106 from MorphoSys and
Continue readingVyriad, a US biotech company, has entered into a collaboration with Germany-based Merck to launch a phase 1 trial of
Continue reading